NasdaqCM - Delayed Quote USD

Accelerate Diagnostics, Inc. (AXDX)

Compare
1.1200
+0.0100
+(0.90%)
At close: 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
11,909.0000
12,059.0000
12,752.0000
11,782.0000
11,165.0000
Cost of Revenue
9,021.0000
9,509.0000
9,449.0000
12,163.0000
6,706.0000
Gross Profit
2,888.0000
2,550.0000
3,303.0000
-381.0000
4,459.0000
Operating Expense
40,996.0000
56,578.0000
66,108.0000
71,179.0000
68,159.0000
Operating Income
-38,108.0000
-54,028.0000
-62,805.0000
-71,560.0000
-63,700.0000
Net Non Operating Interest Income Expense
-10,063.0000
-6,620.0000
-3,220.0000
-15,457.0000
-14,695.0000
Other Income Expense
-4,719.0000
-120.0000
3,455.0000
9,360.0000
192.0000
Pretax Income
-52,890.0000
-60,768.0000
-62,570.0000
-77,657.0000
-78,203.0000
Tax Provision
564.0000
850.0000
-77.0000
45.0000
5.0000
Net Income Common Stockholders
-53,454.0000
-61,618.0000
-62,493.0000
-77,702.0000
-78,208.0000
Diluted NI Available to Com Stockholders
-53,454.0000
-61,618.0000
-62,493.0000
-77,702.0000
-78,208.0000
Basic EPS
-2.59
-4.94
-7.60
-12.60
-14.00
Diluted EPS
-2.59
-4.94
-7.60
-12.60
-14.00
Basic Average Shares
20,644.5000
12,477.0000
8,216.1000
6,172.7000
5,601.0000
Diluted Average Shares
20,644.5000
12,477.0000
8,216.1000
6,172.7000
5,601.0000
Total Operating Income as Reported
-38,108.0000
-54,028.0000
-62,805.0000
-71,560.0000
-63,700.0000
Total Expenses
50,017.0000
66,087.0000
75,557.0000
83,342.0000
74,865.0000
Net Income from Continuing & Discontinued Operation
-53,454.0000
-61,618.0000
-62,493.0000
-77,702.0000
-78,208.0000
Normalized Income
-54,451.7700
-48,619.5620
-66,170.4689
-87,076.3720
-78,391.9600
Interest Income
697.0000
1,123.0000
551.0000
88.0000
855.0000
Interest Expense
10,760.0000
7,743.0000
3,771.0000
15,545.0000
15,550.0000
Net Interest Income
-10,063.0000
-6,620.0000
-3,220.0000
-15,457.0000
-14,695.0000
EBIT
-42,130.0000
-53,025.0000
-58,799.0000
-62,112.0000
-62,653.0000
EBITDA
-38,697.0000
-49,771.0000
-55,799.0000
-59,594.0000
-59,656.0000
Reconciled Cost of Revenue
9,021.0000
9,509.0000
9,449.0000
12,163.0000
6,706.0000
Reconciled Depreciation
3,433.0000
3,254.0000
3,000.0000
2,518.0000
2,997.0000
Net Income from Continuing Operation Net Minority Interest
-53,454.0000
-61,618.0000
-62,493.0000
-77,702.0000
-78,208.0000
Total Unusual Items Excluding Goodwill
1,263.0000
-13,183.0000
3,682.0000
9,380.0000
252.0000
Total Unusual Items
1,263.0000
-13,183.0000
3,682.0000
9,380.0000
252.0000
Normalized EBITDA
-39,960.0000
-36,588.0000
-59,481.0000
-68,974.0000
-59,908.0000
Tax Rate for Calcs
0.0002
0.0000
0.0000
0.0000
0.0003
Tax Effect of Unusual Items
265.2300
-184.5620
4.5311
5.6280
68.0400
12/31/2020 - 4/7/1994

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

APYX Apyx Medical Corporation
1.4200
-3.40%
 
KIDS OrthoPediatrics Corp.
26.53
+1.73%
 
ELUT Elutia Inc.
3.2100
-2.13%
 
INBS Intelligent Bio Solutions Inc.
1.3100
0.00%
 
IRMD IRADIMED CORPORATION
58.36
-0.71%
 
NMRD Nemaura Medical Inc.
0.0001
0.00%
 
RPID Rapid Micro Biosystems, Inc.
1.2000
-5.14%
 
DYNT Dynatronics Corporation
0.1357
-3.05%
 
AFIB Acutus Medical, Inc.
0.0550
-21.43%
 
NMTC NeuroOne Medical Technologies Corporation
1.0401
-1.88%